| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/21/2001 | EP1085083A1 Media for culturing animal cells and process for producing protein by using the same |
| 03/21/2001 | EP1085024A1 Peptides having nuclear transport activity |
| 03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1084268A1 Biotechnological production of polyglutaminic acid |
| 03/21/2001 | EP1084262A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 03/21/2001 | EP1084258A1 Industrial method for producing heterologous proteins in e.coli and strains useful for said method |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1084243A2 Protein for regulating apoptosis |
| 03/21/2001 | EP1084241A1 G-protein coupled receptor, named 2871 receptor |
| 03/21/2001 | EP1084234A2 Human deadenylating nuclease, its production and its use |
| 03/21/2001 | EP1084227A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 03/21/2001 | EP1084142A1 Gpr35a receptor |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP0734529B1 Methods and materials for the detection of staphylococcus aureus |
| 03/21/2001 | EP0547201B1 Phagemide for screening antibodies |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288468A Antibodies against human IL-12 |
| 03/21/2001 | CN1288062A Method for producing recombination human interleukin 11 using methyl alcohol yeast |
| 03/21/2001 | CN1063490C Preparation process for full composition pearl crude liquid and pearl powder |
| 03/21/2001 | CN1063488C DNA amplification |
| 03/21/2001 | CN1063343C Hepatitis B surface antigen protein having ammonia end with pre-surface antigen determinant |
| 03/20/2001 | US6204431 Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk |
| 03/20/2001 | US6204367 Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204362 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204057 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204034 Leukotriene C4 synthase |
| 03/20/2001 | US6204018 66 kDa antigen from Borrelia |
| 03/20/2001 | US6204012 Protein production process |
| 03/20/2001 | US6204007 Antibodies against E-selectin |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203998 Human dopamine receptor and its uses |
| 03/20/2001 | US6203995 Agouti-related transcript antibodies and methods of use |
| 03/20/2001 | US6203987 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203798 Lyme disease diagnosis and vaccines; genetic engineering |
| 03/20/2001 | CA2211385C N-1-carboxyalkyl derivatives of lsd |
| 03/20/2001 | CA2098303C Synthetic bioadhesive polypeptide |
| 03/20/2001 | CA2022959C Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
| 03/15/2001 | WO2001018547A1 Essential genes and assays relating thereto |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018229A1 Processes for making protein hydrolysates from animal peptone and for preserving mucosa |
| 03/15/2001 | WO2001018228A1 HUMAN sbgFGF-10a |
| 03/15/2001 | WO2001018227A1 Novel compound f-15078 |
| 03/15/2001 | WO2001018215A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018203A1 Opg fusion protein compositions and methods |
| 03/15/2001 | WO2001018198A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | WO2001018196A1 Method of detecting trichothecene mycotoxins and reagent thereof |
| 03/15/2001 | WO2001018185A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | WO2001018182A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | WO2001018179A1 Cyclic depsipeptide synthases, genes thereof and mass production system of cyclic depsipeptide |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018175A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2000066761A3 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | CA2848454A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/15/2001 | CA2403330A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384123A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383767A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | CA2383758A1 Novel compound f-15078 |
| 03/15/2001 | CA2383563A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | CA2382729A1 29 human cancer associated proteins |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2377905A1 Method and reagent for detection of trichothecene mycotoxins |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348657A1 Cloning, expression and characterisation of the spg4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 03/14/2001 | EP1083226A1 Cell separation device and separation method |
| 03/14/2001 | EP1082875A1 Improved brush block housing for propeller deicing system |